Personalized therapy on the horizon for squamous cell carcinoma of the lung
- 1 June 2013
- journal article
- review article
- Published by Elsevier BV in Lung Cancer
- Vol. 80 (3), 249-255
- https://doi.org/10.1016/j.lungcan.2013.02.015
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplificationBritish Journal of Cancer, 2011
- The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical TargetsMolecular Cell, 2010
- A small-cell lung cancer genome with complex signatures of tobacco exposureNature, 2009
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasNature Genetics, 2009
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesisNature, 2008
- Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencingNature Genetics, 2008
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005